Additionally, there have been case reports proving that therapy of some cases of ALK-positive IMT with Crizotinib, especially those in which surgery is contraindicated and cases of unresectable lesions, multifocal disease, or postoperative recurrence, could effectively inhibit tumor growth and decrease tumor size [22]. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.